JP2014530818A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530818A5 JP2014530818A5 JP2014535757A JP2014535757A JP2014530818A5 JP 2014530818 A5 JP2014530818 A5 JP 2014530818A5 JP 2014535757 A JP2014535757 A JP 2014535757A JP 2014535757 A JP2014535757 A JP 2014535757A JP 2014530818 A5 JP2014530818 A5 JP 2014530818A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- methyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*IC([C@@]1(C)O*1)Nc(c(*)c1Cl)ccc1N Chemical compound C*IC([C@@]1(C)O*1)Nc(c(*)c1Cl)ccc1N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161546711P | 2011-10-13 | 2011-10-13 | |
| US61/546,711 | 2011-10-13 | ||
| PCT/US2012/058824 WO2013055577A1 (en) | 2011-10-13 | 2012-10-05 | Selective androgen receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530818A JP2014530818A (ja) | 2014-11-20 |
| JP2014530818A5 true JP2014530818A5 (en:Method) | 2015-11-12 |
| JP6002228B2 JP6002228B2 (ja) | 2016-10-05 |
Family
ID=47046879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535757A Active JP6002228B2 (ja) | 2011-10-13 | 2012-10-05 | 選択的アンドロゲン受容体調節剤 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8658693B2 (en:Method) |
| EP (1) | EP2766350B1 (en:Method) |
| JP (1) | JP6002228B2 (en:Method) |
| KR (1) | KR20140067102A (en:Method) |
| CN (1) | CN103842348B (en:Method) |
| AP (1) | AP2014007548A0 (en:Method) |
| AR (1) | AR088082A1 (en:Method) |
| AU (1) | AU2012321113B2 (en:Method) |
| BR (1) | BR112014008668A2 (en:Method) |
| CA (1) | CA2847889A1 (en:Method) |
| CL (1) | CL2014000895A1 (en:Method) |
| CO (1) | CO6910195A2 (en:Method) |
| CR (1) | CR20140156A (en:Method) |
| DO (1) | DOP2014000075A (en:Method) |
| EA (1) | EA201490519A1 (en:Method) |
| EC (1) | ECSP14013305A (en:Method) |
| ES (1) | ES2626820T3 (en:Method) |
| GT (1) | GT201400067A (en:Method) |
| IL (1) | IL231440A0 (en:Method) |
| MX (1) | MX2014004558A (en:Method) |
| PE (1) | PE20141669A1 (en:Method) |
| PH (1) | PH12014500808A1 (en:Method) |
| PL (1) | PL2766350T3 (en:Method) |
| PT (1) | PT2766350T (en:Method) |
| SG (1) | SG11201401794YA (en:Method) |
| TN (1) | TN2014000136A1 (en:Method) |
| TW (1) | TWI449686B (en:Method) |
| WO (1) | WO2013055577A1 (en:Method) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140045856A1 (en) | 2012-07-31 | 2014-02-13 | Boehringer Ingelheim International Gmbh | 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes |
| TW201534586A (zh) * | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎ｃｙｐ１７抑制劑／抗雄激素劑 |
| AU2014359456B2 (en) | 2013-12-04 | 2019-01-24 | Evotec International Gmbh | Sulfoximine substituted quinazolines for pharmaceutical compositions |
| US9682960B2 (en) | 2013-12-19 | 2017-06-20 | Endorecherche, Inc. | Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety |
| CA2944103A1 (en) | 2014-05-07 | 2015-11-12 | Evotec International Gmbh | Sulfoximine substituted quinazolines for pharmaceutical compositions |
| MA45920B1 (fr) | 2016-08-15 | 2021-08-31 | Pfizer | Inhibiteurs de pyridopyrimidinone cdk2/4/6 |
| SI3507289T1 (sl) | 2016-09-02 | 2020-11-30 | Suven Life Sciences Limited, | Pozitivni alosterični modulatorji muskarinskih M1 receptorjev |
| US11076596B2 (en) | 2017-09-18 | 2021-08-03 | Basf Se | Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi |
| KR20230027213A (ko) * | 2020-06-24 | 2023-02-27 | 셀진 코포레이션 | 세레블론 결합 화합물, 이의 조성물, 및 이에 의한 치료 방법 |
| WO2025104624A1 (en) * | 2023-11-14 | 2025-05-22 | Pfizer Inc. | Synthesis of 1,5-anhydro-3-({5-chloro-4-[4-fluoro-2-(2-hydroxypropan-2-yl)-1-(propan-2-yl)-1h-benzimidazol-6-yl]pyrimidin-2-yl}amino)-2,3-dideoxy-d-threo-pentitol |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594405A (en) * | 1968-05-17 | 1971-07-20 | Du Pont | Substituted pyranyl anilines as plant growth modifiers |
| ATE315555T1 (de) * | 2001-05-11 | 2006-02-15 | Pfizer Prod Inc | Thiazolderivate und ihre verwendung als cdk- inhibitoren |
| US8519158B2 (en) * | 2004-03-12 | 2013-08-27 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
| PT1891038E (pt) * | 2005-05-13 | 2008-12-02 | Lilly Co Eli | N-arilpirrolidinas substituídas como moduladores selectivos do receptor de androgénio |
| JP5169220B2 (ja) * | 2005-11-30 | 2013-03-27 | アステラス製薬株式会社 | ２−アミノベンズアミド誘導体 |
| WO2008130879A2 (en) * | 2007-04-16 | 2008-10-30 | Serenex, Inc. | Tetrahydroindole and tetrahydroindazole derivatives |
| US8190467B2 (en) * | 2007-10-19 | 2012-05-29 | Michelle Letendre-Hedlund | Methods of identifying environmentally friendly businesses or individuals |
| BRPI0907844B8 (pt) * | 2008-02-22 | 2021-05-25 | Radius Health Inc | compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos |
-
2012
- 2012-09-27 AR ARP120103597A patent/AR088082A1/es unknown
- 2012-09-28 TW TW101136038A patent/TWI449686B/zh not_active IP Right Cessation
- 2012-10-05 SG SG11201401794YA patent/SG11201401794YA/en unknown
- 2012-10-05 WO PCT/US2012/058824 patent/WO2013055577A1/en not_active Ceased
- 2012-10-05 PL PL12775406T patent/PL2766350T3/pl unknown
- 2012-10-05 AP AP2014007548A patent/AP2014007548A0/xx unknown
- 2012-10-05 CA CA2847889A patent/CA2847889A1/en not_active Abandoned
- 2012-10-05 PE PE2014000521A patent/PE20141669A1/es not_active Application Discontinuation
- 2012-10-05 EA EA201490519A patent/EA201490519A1/ru unknown
- 2012-10-05 CN CN201280049445.8A patent/CN103842348B/zh active Active
- 2012-10-05 PT PT127754067T patent/PT2766350T/pt unknown
- 2012-10-05 BR BR112014008668A patent/BR112014008668A2/pt not_active IP Right Cessation
- 2012-10-05 ES ES12775406.7T patent/ES2626820T3/es active Active
- 2012-10-05 AU AU2012321113A patent/AU2012321113B2/en not_active Ceased
- 2012-10-05 MX MX2014004558A patent/MX2014004558A/es not_active Application Discontinuation
- 2012-10-05 EP EP12775406.7A patent/EP2766350B1/en active Active
- 2012-10-05 JP JP2014535757A patent/JP6002228B2/ja active Active
- 2012-10-05 PH PH1/2014/500808A patent/PH12014500808A1/en unknown
- 2012-10-05 KR KR1020147009338A patent/KR20140067102A/ko not_active Abandoned
- 2012-10-05 US US13/645,535 patent/US8658693B2/en active Active
-
2014
- 2014-03-10 IL IL231440A patent/IL231440A0/en unknown
- 2014-03-17 CO CO14057028A patent/CO6910195A2/es unknown
- 2014-03-28 TN TNP2014000136A patent/TN2014000136A1/en unknown
- 2014-04-04 CR CR20140156A patent/CR20140156A/es unknown
- 2014-04-10 CL CL2014000895A patent/CL2014000895A1/es unknown
- 2014-04-11 EC ECSP14013305 patent/ECSP14013305A/es unknown
- 2014-04-11 DO DO2014000075A patent/DOP2014000075A/es unknown
- 2014-04-11 GT GT201400067A patent/GT201400067A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530818A5 (en:Method) | ||
| JP2021530565A5 (en:Method) | ||
| JP2019524883A5 (en:Method) | ||
| JP2018035160A5 (en:Method) | ||
| CN113784970A (zh) | Erk抑制剂及其应用 | |
| JP2016501221A5 (en:Method) | ||
| JP2011529054A5 (en:Method) | ||
| JP2015537020A5 (en:Method) | ||
| JP2013509429A5 (en:Method) | ||
| JP2020097577A5 (en:Method) | ||
| EP4241772A3 (en) | Process for the preparation of compounds useful for treating spinal muscular atrophy | |
| JP2020511467A5 (en:Method) | ||
| JP2013032389A5 (en:Method) | ||
| JP2014500861A5 (en:Method) | ||
| JP2014524442A5 (en:Method) | ||
| JP2016534063A5 (en:Method) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2016065042A5 (en:Method) | ||
| JP2013512277A5 (en:Method) | ||
| JP2012506872A5 (en:Method) | ||
| JP2017517565A5 (en:Method) | ||
| JP2013503134A5 (en:Method) | ||
| RU2015134420A (ru) | Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты | |
| JP2019151627A5 (en:Method) | ||
| JP2015522037A5 (en:Method) |